Each Hour Counts: Physician and Pharmacist Perspectives on the Value of Rapid Blood Culture Testing
Sepsis is the most expensive condition to treat in the U.S. and is one of the deadliest diseases. Delayed identification of the causative bacterium and associated antimicrobial resistance can hinder effective treatment and worsen patient outcomes. Rapid identification of these pathogens provides vital information for clinicians to determine the best treatment for their patients. Effective implementation of rapid diagnostics for sepsis is associated with improved patient outcomes, improved antimicrobial stewardship, and reduced healthcare costs. This complimentary webinar will give an in-depth look at how rapid blood culture diagnostics are impacting the clinicians that manage patients with bloodstream infections and those who are driving antimicrobial stewardship and infection control initiatives in hospitals.